金盾股份12月19日公告，公司第五届董事会第十次会议审议通过《关于聘任董事会秘书的议案》，同意 聘任兰通为公司董事会秘书，任期自董事会审议通过之日起至第五届董事会任期届满之日止。公司董事 长王淼根不再代行董事会秘书职责。 ...

Core Viewpoint - The company, DeGute, is positioned to benefit from trends in carbon neutrality, waste treatment, hydrogen energy, and the depreciation of the RMB, with a focus on energy-saving and environmental protection technologies. Group 1: Company Overview - DeGute specializes in the design, manufacturing, and sales of energy-saving and environmental protection equipment, with a revenue composition of 76.84% from energy-saving heat exchange equipment, 8.40% from equipment maintenance and modification, and smaller percentages from other categories [8]. - The company was established on April 5, 2004, and went public on March 3, 2021, with a current market capitalization of 3.448 billion yuan [8]. Group 2: Product and Technology - The company has developed high-temperature air preheaters for gasification processes, which can increase production by 45% and save fuel by 9.3%-13.2% while reducing carbon emissions [2]. - DeGute has entered the hydrogen energy production sector, providing energy-saving heat exchange and storage equipment, and possesses the design qualifications for pressure vessels [2]. Group 3: Market Position and Recognition - DeGute has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, indicating its strong market position and technological capabilities [3]. - The company has a significant overseas revenue share of 59.28%, benefiting from the depreciation of the RMB [4]. Group 4: Financial Performance - For the period from January to September 2025, DeGute reported a revenue of 382 million yuan, a year-on-year decrease of 9.29%, and a net profit of 72.26 million yuan, down 26.39% year-on-year [9].

Core Viewpoint - The stock of Maide Medical (688310) has shown a slight increase, with a closing price of 14.78 yuan on December 18, 2025, reflecting a 0.48% rise, amidst mixed capital flows from different investor types [1]. Group 1: Stock Performance and Capital Flow - On December 18, 2025, Maide Medical's stock recorded a trading volume of 28,400 hands and a total transaction amount of 42.35 million yuan [1]. - The net inflow of main funds was 194,600 yuan, accounting for 0.46% of the total transaction amount, while retail investors saw a net inflow of 469,700 yuan, representing 1.11% [1]. - Over the past five days, the stock has experienced fluctuations in capital flow, with notable net inflows and outflows from different investor categories [2]. Group 2: Financial Metrics and Industry Comparison - Maide Medical's total market value is 2.457 billion yuan, significantly lower than the industry average of 7.693 billion yuan, ranking 227 out of 270 in the specialized equipment industry [3]. - The company reported a net profit of 8.8367 million yuan for the first three quarters of 2025, which is a 15.82% increase year-on-year, while its main revenue reached 225 million yuan, up 2.31% year-on-year [3]. - The gross profit margin stands at 40.19%, which is higher than the industry average of 27.79%, but the net profit margin is negative at -2.43%, significantly below the industry average of 4.37% [3].

Group 1 - A total of 78 stocks in the A-share market experienced block trading today, with a total transaction value of 3.755 billion yuan [1] - The top three stocks by transaction value were Minsheng Bank (2.149 billion yuan), WuXi AppTec (430 million yuan), and Luxin Technology (119 million yuan) [1] - Among the stocks, 8 were traded at par, 3 at a premium, and 67 at a discount; the highest premium rates were for AVIC Optoelectronics (8.04%), Zhongke Shuguang (7.92%), and Haowei Group (2.07%) [1] Group 2 - The top buying amounts from institutional special seats were led by WuXi AppTec (251 million yuan) and Minsheng Bank (108 million yuan) [2] - The top selling amounts from institutional special seats included Jintian Titanium Industry (18.74 million yuan) and Huilong New Materials (9.97 million yuan) [2]

格隆汇12月18日丨科达制造(600499.SH)在投资者互动平台表示，公司前期勘测区域未发现具备商业开 采价值的锂矿资源。 ...

Group 1 - The specialized equipment sector experienced a decline of 1.02% compared to the previous trading day, with the leading decline from the Yunjigroup [1] - The Shanghai Composite Index closed at 3876.37, reflecting an increase of 0.16%, while the Shenzhen Component Index closed at 13053.98, showing a decrease of 1.29% [1] - A detailed table of individual stock performance within the specialized equipment sector was provided [1] Group 2 - The net capital outflow from the specialized equipment sector amounted to 3.022 billion yuan, while the net inflow from speculative funds was 586 million yuan, and retail investors contributed a net inflow of 2.436 billion yuan [2] - A detailed table of capital flow for individual stocks within the specialized equipment sector was included [2]

Core Insights - On December 17, 2023, brokerage firms provided target prices for listed companies, with notable increases for Honglu Steel Structure (002541), Jiuzhou Pharmaceutical (603456), and Huarui Precision, showing target price increases of 56.76%, 48.99%, and 36.02% respectively, across the professional engineering, medical services, and general equipment industries [1][2]. Target Price Increases - Honglu Steel Structure (002541) received a target price of 25.27 yuan, with a target increase of 56.76% from Guotai Junan Securities [2]. - Jiuzhou Pharmaceutical (603456) has a target price of 26.64 yuan, reflecting a 48.99% increase from Huachuang Securities [2]. - Huarui Precision (688059) was assigned a target price of 110.05 yuan, indicating a 36.02% increase from Guotou Securities [2]. - Other companies with significant target price increases include Hefeng Co. (603609) at 32.58%, Tianci Materials (002709) at 27.56%, and Anfu Technology (603031) at 26.56% [2]. Rating Adjustments - On December 17, only one company had its rating upgraded, with Qunyi Securities (Hong Kong) raising Tianci Materials (002709) from "Hold" to "Buy" [3][4]. First Coverage - A total of nine companies received initial coverage on December 17, including SAIC Motor (600104) and Weilan Lithium (002245), both rated "Buy" by Aijian Securities [4][5]. - Jiuzhou Pharmaceutical (603456) was also rated "Recommended" by Huachuang Securities, while Zhongke Chuangda (300496) and Kema Technology (301611) received "Buy" and "Increase" ratings from Dongbei Securities [4][5].

卓然股份（688121.SH）12月17日在投资者互动平台表示，公司近两年有产品出口欧盟国家，但因行业 周期性波动和全球经济环境变化，出口业务整体占比较低。 （文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：注意到贵公司覆盖欧美、中东、东南亚等地区，请问 近两年是否出口欧盟国家？ ...

从资金流向上来看，当日专用设备板块主力资金净流入13.11亿元，游资资金净流出13.76亿元，散户资 金净流入6474.57万元。专用设备板块个股资金流向见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 证券之星消息，12月17日专用设备板块较上一交易日上涨1.95%，航天晨光领涨。当日上证指数报收于 3870.28，上涨1.19%。深证成指报收于13224.51，上涨2.4%。专用设备板块个股涨跌见下表： ...

12月17日，A股三大指集体上涨，截至收盘，沪指涨1.19%报3870.28点，深成指涨2.4%报13224.51点，创业板指涨3.39%报 3175.91点。从板块行情上来看，今日表现较好的是光通信模块、CPO概念和PCB，而空间站概念、天基互联和北斗导航等 板块下跌。 基金经理是一只基金产品最核心的成员，能决定一只基金的投资方向、投资策略以及投资风格，基金经理出色的择时选股 能力和调研预测能力是基金业绩的有力保证，所以基金经理是投资者在选择基金产品时的重要依据。基金经理的变动很大 程度上会影响到基金产品未来的表现，是一个需要特别关注的信息。12月17日共有14位基金经理发生任职变动。 根据巨灵统计的数据，近30天（11.17-12.17）共有654只基金产品的基金经理发生离职。其中今天（12.17）有17只基金产品 发布基金经理离职公告，涉及6名基金经理。从变动原因上来看，有2位基金经理是由于工作变动而从管理的3只基金产品中 离职。有1位基金经理是由于个人原因而从管理的8只基金产品中离职。有3位基金经理是由于产品到期而从管理的6只基金 产品中离职。 | | 近一个月套金调研总量排行 | | | 近一周基金 ...